Hong Kong, 16 Dec 2024 – Gene Solutions is thrilled to announce the appointment of Jason Mann, MD, PhD, as Strategic Advisor to the Board of Directors. Dr. Mann brings over two decades of expertise in healthcare, life sciences, and investment, particularly in the Asian market.
About Dr. Jason Mann’s Career and Expertise
Dr. Jason Mann, with degrees from Harvard and Vanderbilt, has built a distinguished career advising or investing in over 100 therapeutics, diagnostics, digital health, and healthcare service businesses around the world. Since completing his PhD in cancer with Dr. Raymond Dubois, past President of the American Association for Cancer Research, he has held significant management positions including Managing Director of International Hospitals Group and Managing Director of the Ping An Global Voyager Fund. Dr. Mann began his career at Harvard Medical School and Harvard Business School, combining interest in medical innovation and emerging markets in Asia. Recent senior advisory roles include Eight Roads, Novo Ventures, and many others. Dr. Mann focused on innovation and growth while at McKinsey & Company and has invested in healthcare globally for over 25 years.
Empowering Personalized Cancer Care in the Region
Dr. Mann’s strategic insights are expected to drive Gene Solutions’ growth and innovation in personalized cancer care across Asia. The company, renowned for its world-class genomic research capability, AI-driven analysis, and CAP-accredited next-generation sequencing laboratories in Singapore and Vietnam, offers cutting-edge testing services for early cancer detection, recurrence monitoring, and more.
Dr. Mann said, “My business focus is scaling new technology to generate strong returns and real-world impact. I’m delighted to work with the Gene Solutions team, which is delivering on a vision to empower millions of people through affordable smart tests that find cancer early. Once found, these tests guide personalized cancer treatment to help patients live better, longer. I looked for this business 20 years ago but the technology did not yet exist. Alongside this dedicated team, I hope to play a small part in helping more people navigate cancer successfully while achieving the next phase of growth at Gene Solutions.”
In addition to corporate strategy and financing work, Dr. Mann will advise on market entry and expansion strategies in APAC markets, leveraging his extensive knowledge and international network. His guidance will be crucial in navigating the complexities and seizing the opportunities within these regions.
Gene Solutions looks forward to the transformative impact and global reach that Dr. Jason Mann will bring. Stay tuned to our website and social media for the latest updates on our advancements and initiatives.
